Search

Brian Trantow Phones & Addresses

  • San Francisco, CA
  • 165597 Trappe Rd, Wausau, WI 54403
  • Cambridge, MA
  • Boston, MA
  • East Palo Alto, CA
  • Menlo Park, CA

Resumes

Resumes

Brian Trantow Photo 1

Manager

View page
Location:
260 King St, San Francisco, CA 94107
Industry:
Pharmaceuticals
Work:
Blueprint Research Group Apr 2015 - Nov 2017
Senior Consultant

Blueprint Research Group Apr 2015 - Nov 2017
Manager

Blueprint Research Group Apr 2015 - Aug 2016
Consultant

Putnam Associates Jan 2013 - Feb 2015
Senior Associate and Consultant

Stanford University Sep 2007 - Dec 2012
Nsf Graduate Research Fellow
Education:
Stanford University 2007 - 2012
Doctorates, Doctor of Philosophy, Biology, Chemistry, Organic Chemistry
Yale University 2003 - 2007
Master of Science, Masters, Bachelors, Bachelor of Science, Chemistry
Skills:
Biotechnology
Pharmaceutical Industry
Strategic Planning
Strategy
Market Research
Data Analysis
Chemistry
Lifesciences
Science
Organic Chemistry
Business Strategy
Competitive Strategies
Drug Discovery
Biotechnology Industry
Drug Delivery
Oncology
Rare Diseases
Vaccines
Research
Life Sciences
Microsoft Excel
Powerpoint
Healthcare Consulting
Healthcare
Competitive Analysis
Analysis
Healthcare Reimbursement
Market Analysis
Market Planning
Analytics
Strategic Consulting
Forecasting
Project Management
Hematology
Breast Cancer
Management
Competitive Intelligence
Situation Analysis
Interests:
Science and Technology
Environment
Arts and Culture
Health
Brian Trantow Photo 2

Brian Trantow

View page

Publications

Us Patents

Oligocarbonate Molecular Transporters

View page
US Patent:
20100280219, Nov 4, 2010
Filed:
Apr 30, 2009
Appl. No.:
12/433693
Inventors:
Christina Cooley - Palo Alto CA, US
James L. Hedrick - San Jose CA, US
Matthew Kiesewetter - Stanford CA, US
Fredrik Nederberg - Greenville DE, US
Brian Trantow - Mountain View CA, US
Robert Waymouth - Palo Alto CA, US
Paul Wender - Menlo Park CA, US
International Classification:
C08G 64/02
C07D 323/04
C08G 64/30
US Classification:
528403, 549228
Abstract:
A cyclic carbonate monomer, including:P is a protecting group.The cylic carbonate monomer can be reacted with an initiator including a drug, drug candidate, probe or other molecule of interest to form an oligomer with the molecule of interest attached to one end of a carbonate backbone and guanidine groups attached to the carbonate backbone.
Brian M Trantow from San Francisco, CA, age ~40 Get Report